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Tri effects ofhuman tumour necrosis factor- (TNF), or
its mutein (F4168) having the cell adhesive Arg-Gly-Asp
sequence at the N-terminus, on intestinal injury, were
examined. Histopathological examination revealed that
an intravenous injection of TNF resulted in marked
haemorrhage or oedema in the caecum of rats, whereas
F4168 showed no such effects even at the same therapeu-
tic dose. Moreover, the number of neutrophils that ad-
hered to endothelial cells or infiltrated the mucosal tissue
was much higher after TNF injection compared with
F4168 in vtvo. The enhanced adhesion of neutrophils on
to human umbilical vein endothelial cells also occurred
when the latter were pre-stimulated with TNF but not
with F4168 in vitro. The expression of the cell adhesion
molecules including endothelial leukocyte adhesion mol-
ecule-1 or intercellular adhesion molecule-I on F4168-
stimulated human umbilical vein endothelial ceils was
significantly lower than that stimulated withTNF. These
results suggest that the Arg-Gly-Asp sequence introduced
into the TNF molecule abrogates the side effect of this
cytokine such as tissue injury or shock, and that F4168
could be useful for systemic therapy.
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Introduction
TNFot is a multi-functional cytokine which was
originally identified as a serum factor that induced
necrotic responses of solid tumours in vivo.
Although TNFot exerts antitumour effects against
various tumour cell lines,>3 it also has hypotensive4,5
or tumour metastasis-enhancing effects. Moreover,
TNFot induces shock and injury including intestinal
necrosis in rats or mice when it is administered with
or without LPS.4’5’9-1 Thus, for clinical applications, it
is necessary to reduce these side-effects of TNF0t
while maintaining its antitumour potential. It was
demonstrated previously that a TNF mutein (F4236)
having the laminin derived cell-adhesive peptide
(YIGSR) did not enhance experimental pulmonary
metastasis in contrast to wild-type TNF. An
Arg-Gly-Asp (RGD) containing mutein (F4168) also
showed similar properties. Here, the effect of F4168
on inflammatory reactions, including shock and
tissue injury in rats, has been examined.
Materials and Methods
Construction of expression plasmids: The human
TNF0t gene prepared with synthetic oligonucleotides
was used to construct the expression plasmid
pKF4102 for wild-type TNF0t. The expression
plasmid pKF4168 was used for the mutein (F4168)
having the tripeptide Arg-Gly-Asp (RGD) near the
N-terminus of human TNF. This was introduced
into the wild-type TNF gene by site-directed
mutagenesis.
1" The construction of pKF4168 involved
the substitution of Gly-Asp for the 5Thr-6Pro of wild-
type TNF0t. Both pKF4102 and pKF4168 have the tac
promoter.
Production and purification of TNF and F4168:
The expression plasmids were induced by adding
IPTG (isopropyl--D-thio-galactopyranoside) into the
Escherichia coli (K12 JM103) culture medium (M9).
These proteins were expressed in E. coli, extracted
by sonication and purified to homogeneity by se-
quential anion exchange chromatography using
Sepabeads FP-DA13 (Mitsubishi Chemical Industries
Co., Tokyo, Japan) and Mono Q (Pharmacia LKB
Biotechnology, Uppsala, Sweden). The specific activ-
ity of both TNF and F4168 was 3 x 107 units/mg
protein. The protein content was determined by a
dye-binding method. 13
The effect of TNF or F4168 on tissue injury: Male
Sprague-Dawley rats (220+_25 g; Crj; CD) were
housed in standard cages and given food and water
ad libitum in a temperature controlled room
(24 _+ 1C) with a 12 h dark/light cycle until surgery.
TNF and F4168 dissolved in saline were intraven-
ously injected at a dose of 20 l.tg/500 l.d/rat. The
animals were sacrificed 6 h after injection using CO,.
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gas. A complete post-mortem examination including
sampling of digestive organs for histopathological
examination was performed. The digestive organs
were fixed in 10% neutral buffered formalin, pro-
cessed by conventional methods, embedded in par-
affin, cut into 4/.tm thick sections, then stained with
haematoxylin and eosin.
Isolation and culture of human umbilical vein
endothelial cells: Human umbilical vein endothelial
cells (HUVEC) were prepared by collagenase diges-
tion of umbilical veins essentially according to the
method of Jaffe et al. 14 Isolated cells were routinely
cultured in growth media consisting of MCDB107
(Kyokuto Pharmaceutical Industrial Co. Ltd, Japan)
supplemented with endothelial cell growth supple-
ment (50 lag/ml; Collaborative Research Inc.),
heparin (50/.tg/ml; Sigma), penicillin (100 units/ml),
streptomycin (100 lttg/ml) and 10% FBS (Gibco).
Cultures were free of contaminating fibroblast and
smooth muscle cell as assessed by the expression of
Factor VIII-related antigen and uptake of acetylated
low density lipoprotein and were used up to passage
five. The cells were harvested from 35 mm gelatin
precoated tissue culture plates (Corning) by expo-
sure to 0.125% trypsin with 1 mM EDTA for 2-3 min.
Cells (1 x 104/well) were seeded onto 96-well plates
(Corning) which were precoated with 0.5% gelatin
for 30 min at 37C. Cells were cultured for a further
3-4 days before the assay.
Neutrophil adhesion assay: Neutrophils were iso-
lated from the peripheral blood of healthy adult
volunteers by density gradient centrifugation with
PolymorphprepTM (Nycomed Pharma AS, Oslo, Nor-
way). Confluent HUVEC were incubated with 0.1 ng/
ml TNF0t or F4168 for 4 h at 37C. The wells were
then gently washed twice with MCDB 107 supple-
mented with 10% FBS. Neutrophils were added
(2 x 105 cells/100 btl/well) onto the factor stimulated
HUVEC and allowed to attach for 30 min at 37C. The
non-adherent cells were then removed and the wells
were washed three times with phosphate buffered
saline (PBS). The adherent cells were fixed in 3:7%
buffered formalin. The number of neutrophils that
adhered to the HUVEC was counted in five fields (1
mm2) for each well.
Antibodies and other reagents: Mouse IgG anti-hu-
man ELAM-1 (BBA1) and mouse IgG anti-human
ICAM-1 (BBA3) were obtained from British Bio-tech-
nology Products Ltd. Anti-mouse IgG(H+L) and the
avidin-biotinylated peroxidase kit were from Vector
Laboratories, Inc.
ELISA: ELAM-1 and ICAM-1 expression on HUVEC
was measured using an ELISA. Confluent cultures of
HUVEC were stimulated with several concentrations
of TNFz or mutein in culture medium. HUVEC were
fixed with 3.7% buffered formalin, then washed with
0.5% BSA in PBS (BSA buffer) four times. Fc receptors
were blocked by incubating with horse serum (di-
luted 1:50 in BSA buffer) for 1 h at 37C. The cells
were then washed and incubated with mouse anti-
human ELAM-1 (diluted 1:2 000) or mouse anti-hu-
man ICAM-1 (diluted 1:1 000) with BSA buffer for 1
h at 37C. The cells were washed and incubated with
biotinylated horse anti-mouse IgG with BSA buffer
for 1 h, followed by another wash and incubation
with avidin-biotinylated peroxidase. Binding was
assessed by adding 100 /.tl of 0.1 mg/ml
tetramethylbenzidine with 0.3% H202 in distilled
water. The reaction was stopped with 4 N sulphuric
acid, and plates were read on an ELISA plate reader
(Bio-Rad) at an OD of 450 nm. The degree of specific
mAb binding was calculated by subtracting the non-
specific binding of the negative control from all test
values.
Results
The acute toxicity caused by the intravenous injec-
tion of TNFcz or F4168 in rats has been examined.
Since the maximal hypotensive effect in rats and
serious tissue injury in mice were observed 6 to 8 h
after TNFz injection, the rats were killed for necropsy
and histopathological examinations 6 h after TNFz or
F4168 injection.
At necropsy, several gross abnormalities of the
caecum including marked thickening of the walls or
focal haemorrhage were apparent in rats injected
with TNF0t. Histopathological sections through the
caecum 6 h after TNF0t injection (20 lag) revealed an
inflammatory response with haemorrhage in the
lamina propria mucosae or infiltration of leukocytes
(Fig. 1A). The venule of the tunica submucosa was
dilated, and invasion of leukocytes was also ob-
served. A detailed histopathological examination of
the venule revealed the adhesion of neutrophils on
the vessel wall or infiltration into the surrounding
mucosal tissues (Fig. 1B). In contrast, rats injected
with F4168 had a reduced inflammatory response
compared with the TNF0t administered group. Haem-
orrhage was rarely observed (Fig. 1D), and the
number of lymphocytes or neutrophils adhering or
infiltrating in mucosa was relatively small in the
F4168 administered group (Fig. 1E). Table 1 shows
the comparison of the effects of TNFcz and F4168 on
several histopathological findings. Similar results
were obtained for the duodenum of mice injected
with TNFc or F4168 (data not shown).
The effect of TNF0t or F4168 on the neutrophil
adhesion to HUVEC in vitro (Fig. 2) also was exam-
ined. Human neutrophils were overlaid on HUVEC
prestimulated with 0.1 ng/ml of TNF0t or F4168, and
the adhesion during 30 min incubation at 37C was
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Fig. 1. The histopathological appearance of the caecum in Sprague-Dawley rats given TNF or F4168. TNF(20 lg/rat) (Panels A, B and C) or F4168
(20 lg/rat) (Panels D and E) was administered intravenously. Six hours later, the rats were sacrificed for histopathological examination. A and D, x 100;
B and E, x 400; C, x 800. There is a large number of neutrophils adhering to the vascular endothelium.
evaluated. The number of adherent neutrophils onto
the F4168-stimulated HUVEC was significantly lower
than that in TNF{x (154 _+ 30 vs. 236 + 49 cells/mm2,
p< 0.01). Similar results were also obtained when
HUVEC were prestimulated with 1 ng/ml of each
factor (data not shown).
The TNF0t or F4168 induced ELAM-1 on HUVEC
were next examined. Although the initial expression
rate of ELAM-1 by TNF or F4168 (0.1 ng/ml, each)
was almost the same, the maximal expression (4 or
6 h after stimulation) by F4168 was significantly
lower than that by TNF0t (Fig. 3). Moreover, the
ELAM-1 induction by TNF0t was dose dependent at
concentrations of 0.01 to 10 ng/ml (Fig. 4). F4168,
however, induced a relatively low level of ELAM-1
expression compared with that by TNF{x at any
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Table 1. Distribution of histopathological findings in the caecum of rats
Findings
Ileocaecum Corpus
Saline TNFo F4168 Saline TNFo F4168
Diffuse dilatation of blood capillaries in lamina propria mucosae 0 0.9 0.3 0 0.2 0.3
Focal erosion 0 0.3 0 0.2 0.5 0.1
Focal necrosis or disappearance of epithelial cells 0 1.3 0.5 0 0.6 0.2
Focal necrosis in lamina propria mucosae 0 0.9 0.4 0 0.4 0.2
Focal infiltration of neutrophil cells in lamina propria mucosae 0.1 0.8 0.4 0 0.7 0.3
Focal infiltration of neutrophil cells in tunica submucosa 0.1 0.5 0.3 0 0.6 0.3
Focal haemorrhage in lamina propria mucosae 0 1.1 0.5 0 0.9 0.5
Focal haemorrhage in tunica submucosa 0 0.3 0.1 0 0.1 0
Oedema in lamina propria mucosae 0.1 0.7 0.4 0 0.3 0.2
Oedema in tunica submucosa 0 1.3 1.0 0.2 1.9 0.9
Sacrificed 6 h after injection (n= 8 for TNFo or F4168 injected group, n=6 for saline control group), aSeverity score--the sum of the
individual intensity of histopathological scores (minimal, 0.5; slight, 1" moderate, 2; marked, 3) divided by the total number of rats per group.
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Fig. 2. Adhesion of isolated neutrophils to TNFo- or F4168-stimulated
HUVEC. HUVEC were stimulated with TNF(z or F4168 (0.1 ng/ml, each) for
4 h at 37C. Neutrophils (2 x 10 cells) were then plated and allowed to
adhere for 30 min and counted. Bars indicate the mean + S.D., and
significance was determined by Student’s t-test.
concentration tested except 10 ng/ml (Fig. 4). Similar
results were also obtained with respect to ICAM-1
(Fig. 5B), suggesting that the RGD sequence in F4168
reduces the enhanced ELAM-1 or ICAM-1 inducibility
of TNF0t.
Although the GRGDS peptide did not affect the
TNF(, mediated enhancement of ELAM-1 expression
(Fig. 5A), it reproducibly (but not significantly) re-
duced the TNF0t mediated ICAM-1 expression at a
dose of 3 or 100 pg/ml (6 and 200 pM, respectively)
(Fig. 5B). On the other hand, F4168 induced signifi-
cantly lower levels of ICAM-1 expression compared
with TNFet at a dose of 0.1 ng/ml (6 pM). These data
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Fig. 3. Time course of ELAM-1 induction on HUVEC. HUVEC were stimu-
lated with 0.1 ng/ml of TNFoq (unfilled circles) or F4168 (filled circles). At the
indicated times, ELAM-1 induction was determined by ELISA. Bars indicate
the mean + S.D., and significance was determined by Student’s t-test
(*p < 0.05; **p < 0.001).
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Fig. 4. Dose dependent up-regulation of ELAM-1 on HUVEC. The cell
surface ELAM-1 level was increased by stimulating HUVEC with TNF(z
(unfilled circles) or F4168 (filled circles) at doses ranging from 0.001 to 10
ng/ml for 4 h. Bars indicate the mean + S.D., and significance was deter-
mined by Student’s t-test (*p 0.005; **p < 0.001).
confirm the effectiveness of the RGD sequence in
F4168 in reducing the enhanced induction of cell
adhesion molecules.
Discussion
It is postulated that the antitumour activity of TNF(x
is completed as the result of the ’primary’ and ’sec-
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FIG. 5. Effect of GRGDS peptide on TNFo-mediated enhancement of cell adhesion molecules. ELAM-1 (A) or ICAM (B) expression after stimulating of
HUVEC with 0.1 ng/ml of TNFo, F4168 or GRGDS peptide (RGD100, 100 pg/ml; RGD3, 3 pg/ml) for 4 h. Bars indicate the mean + S.D., and significance
was determined by Student’s t-test.
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FIG. 6. Growth inhibition against Meth A fibrosarcoma by TNF or F4168. Meth A cells (1 x 106) were transplanted subcutaneously into the back of
BALB/c male mice (6 weeks old). After 8 days, when the tumours were 8 mm in mean diameter, TNF or F4168 was injected intravenously into the tail
vein at a dose of 3 lg (A) or lg (B) per mouse. Tumour volumes were calculated by the formula a//2, where a and b represent the long and short diameters
of the tumor, respectively. O, Control;., TNFoq ,, F4168; Bars indicate the mean _+ S.E.M. (n= 5).
ondary’ inflammation. The ’primary inflammation’
occurs immediately after TNF0t injection and includes
haemorrhage, thrombus formation, congestion of
capillary vessels and complete loss of blood circula-
tion followed by the necrosis of tumour
vasculature. 15 At the same time, adhesion or infiltra-
tion of neutrophils or macrophages on vessel walls
is promoted, which might result in the destruction of
tumour vasculature. These sequential reactions at the
early stage are thought to be mainly concerned with
the expression of the antitumour activity of TNF.
On the other hand, following the primary re-
sponse, a secondary response at the inflammatory
site (tumour region) could occur, in which several
inflammatory cytokines such as IL-1, IL-6 and TNFot
are induced from macrophage or lymphocytes. These
inflammatory cytokines induce several cell adhesion
molecules which promote the interaction between
endothelial cells and leukocytes through their spe-
cific receptors.1-18 Neutrophils accumulated at the
inflammatory site release various proteases or reac-
tive oxygen metabolites which cause the destruction
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of tumour-induced capillary vessels. It is surmised
that such ’secondary inflammation’ promotes the
antitumour activity of TNF0t at a lower concentration.
This study indicates that F4168 is less toxic to the
intestine than is TNF. Based on the
histopathological findings (Fig. 1 and Table 1), it is
speculated that this difference between F4168 and
TNF is accompanied by a varied extent of second-
ary inflammation, especially the accumulation of
activated neutrophils at the inflammatory site. It has
been reported that the binding of leukocytes to
endothelial cells is mediated by cell adhesion mol-
ecules belonging to the selectin or immunoglobulin
family. 19-21 The present results show that ELAM-1 or
ICAM-1 expression on the endothelial cell surface is
up-regulated by TNF stimulation (Figs 3 and 4),
which could be correlated with the enhanced
neutrophil binding to endothelial cells (Fig. 2). Simi-
lar results have been reported by Pober et a/. 21-23 In
contrast, F4168 induced a much lower level of ELAM-
1 or ICAM-1 expression (Fig. 5) and neutrophil bind-
ing (Fig. 2) on endothelial cells compared with that
of TNF0t. Therefore, F4168 should induce neither
excessive rolling and infiltration of neutrophils nor
excessive secondary inflammation in vivo. This may
explain why F4168 does not induce serious intestinal
injury.
It is of particular note that a synthetic GRGDS
pentapeptide has the potential to reduce TNF0
mediated ICAM-1 expression (Fig. 5B), because this
fact could provide a better understanding of the
mechanisms by which F4168 shows much lower
inducibility of cell adhesion molecules. Since F4168
(but not TNF00 mediates the adhesion and spreading
of endothelial cells onto an inert substrate (data not
shown), it is possible that RGD-directed receptor is
involved in the binding of F4168 with endothelial
cells. As described above, stimulation by F4168
through the TNF receptor up-regulates the expres-
sion of adhesion molecules. In contrast, stimulation
through RGD receptors (integrins) may reduce the
excessive TNF mediated expression of adhesion
molecules. Moreover, it is suspected that the RGD
domain in F4168 functions more effectively than an
RGD oligopeptide, because TNF functions as an
effective carrier protein for it. Thus, binding between
the RGD and integrin could effectively occur. An-
other possibility is that truncated F4168, whose TNF
activity is abolished as a result of digestion by
proteases secreted from activated neutrophils,24-26
may also express RGD-derived functions more effec-
tively in vivo. In addition to the low toxic effect of
F4168 on intestinal function, this novel mutein has
the same antitumour potential in mice transplanted
with Meth A fibrosarcoma (Fig. 6). Therefore, this
mutein should be a useful antitumour drug without
the side effects of wild-type TNF0t.
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